BlinkAid
Wearable Device for Blink Monitoring and Prevention of Dry-eye-syndrome
Company Overview
Snapshot
Founded in November 2022 by Yechiam Sapir and Raz Karl, BlinkAid operates with 1–10 employees. The company has secured funding across one round from one investor, with Galil Ofek participating in its Seed round in June 2023.
Business overview
BlinkAid develops a wearable application designed to prevent and alleviate the burden of Dry Eye and Computer Vision Syndromes. The company's core technology utilizes a patented system embedded into personal glasses to monitor blink rates and quality, providing personalized neurostimulation to compensate for improper blinking. BlinkAid aims to be a pioneer in using glasses for medical aid beyond vision correction, specifically addressing Dry Eye Symptoms through the natural blinking mechanism. It operates within the Health Tech & Life Sciences sector, focusing on medical devices, assistive devices, and life support, serving patients, the medical devices industry, and general consumers.
Strategic signal
In September 2024, BlinkAid was featured in a news article by Ynet.co.il, highlighting its innovative approach to solving dry eye syndrome without the need for drops. This media attention signals growing recognition for BlinkAid's non-invasive, wearable technology within the ophthalmology and health tech sectors, suggesting potential for market adoption and further investor interest in its unique solution for a widespread condition.
Log in to access full profile ›Company Intelligence Q&A
- When was BlinkAid founded?
- BlinkAid was founded in November 2022 by co-founders Yechiam Sapir and Raz Karl.
- What is BlinkAid's primary focus?
- BlinkAid focuses on developing a wearable application to prevent and alleviate Dry Eye and Computer Vision Syndromes by monitoring blink rates and providing neurostimulation through smart glasses.
- Which investor participated in BlinkAid's funding round?
- In June 2023, Galil Ofek participated in BlinkAid's Seed funding round.
- What is the core technology behind BlinkAid's solution?
- BlinkAid's solution uses a patented technology embedded in glasses frames to monitor blink rate and quality, providing highly specific and tailored neurostimulation to address improper blinking.
- What market problem does BlinkAid aim to solve?
- BlinkAid aims to address Dry Eye and Computer Vision Syndromes by leveraging the natural mechanism of blinking, offering a non-invasive alternative to traditional treatments.